alexa
ISSN: 2329-6577
Biological Systems: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Organ genomics: what can we learn?

Mun-Kit Choy*
Department of Medicine, University of Cambridge, UK
*Corresponding Author : Mun-Kit Choy
Department of Medicine
University of Cambridge
Addenbrooke’s Hospital
Hills Road, UK
E-mail: mkc27@cam.ac.uk
Received January 05, 2012; Accepted January 07, 2012; Published January 10, 2012
Citation: Choy MK (2012) Organ genomics: what can we learn? Biol Syst 1:e102. doi:10.4172/2329-6577.1000e102
Copyright: © 2012 Choy MK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biological Systems: Open Access

Keywords
Genomics is broadly defined as a discipline concerning the study of the genomes of organisms, however, technically, it can have many different forms depending on the molecular levels or aspects: variomics focuses on sequence or structural variations, epigenomics on DNA or histone modifications, cistromics on cis-elements for transcriptional regulation, transcriptomics on transcribed genomic regions, and interactomics on three-dimensional chromosomal interactions. In medical research, cancer has become the “model disease” to receive all the attention from the genomicists especially with the recent development of high throughput sequencing technologies. In 2007, The International Cancer Genome Consortium was launched to coordinate a few synergetic efforts studying over 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels [1]. A public research consortium named the Encyclopaedia of DNA Elements (ENCODE) has also been launched to identify all functional elements in the human genome using various cell types including a number of cancer cell lines[2]. Recently, methods of studying chromosomal interactions have been coupled with high throughput sequencing, such as ChIA-PET [3] and Hi-C [4], to analyse the interactomes of cancer cells.
Despite the fact that cancer is the leading cause of death worldwide and, thus, being in the limelight of the scientific arena, it is an exceptional case of “gain-of-function” disease unlike other major organ-related diseases that are mostly “loss-of-function”. The genomes within cells accumulate mutations throughout life due to exposure to mutagens or errors in replications. Some of these mutations can up-regulate growth genes or down-regulate growth suppressor genes so the cells “gain” advantages to grow and migrate and therefore become cancerous [2]. Nevertheless, some of these mutations may cause apoptosis or occur in functional genes leading to loss-of-function. One example is from the mice with a deficiency in CuZn superoxide dismutase (CuZnSOD). Without the CuZnSOD to dismutate superoxide radicals generated in the cytoplasm and nucleus, widespread oxidative damage and mutation accumulation were observed in the liver of the mice that presumably has a high oxygen metabolism and vulnerability to oxidative damage [5-7]. As a result, the liver cells in these mice show more occurrences of hepatocarcinogenesis and apoptosis, and reduced life span [5,6].
Cancer genomics concentrates on the genomes of tumours, which are effectively a “clonal population” of a single mutant cell, trying to understand the transformation process. For organ genomics however, a metagenomic approach has to be used because of the lack of clonal expansion of the cell carrying the culprit mutation. A tissue sample from a failing organ represents a mixture of cells bearing various types of mutations, a portion of which cause the loss-of-function. The loss-offunction mutations can be mutations accumulated to trigger apoptosis or mutations causing the dysfunction of organ-specific genes. The lossof- function mutations should be commonly observed in the failing organ samples collected from patient groups having a sufficient sample size, although some apoptosis-causing mutations can be non-specific (Figure 1). Together with epigenomic, cistromic, transcriptomic and even interactomic sequencings, the nature of the mutations can be further characterised.
Acknowledgements
MKC is supported by British Heart Foundation.
References

 

Figures at a glance

Figure
Figure 1
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11337
  • [From(publication date):
    December-2012 - Dec 07, 2016]
  • Breakdown by view type
  • HTML page views : 7605
  • PDF downloads :3732
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version